Global Cancer Biomarkers Market Growth 2020-2025

January 2021 | 165 pages | ID: G59C30A02C00EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, over the next five years the Cancer Biomarkers market will register a 7.2%% CAGR in terms of revenue, the global market size will reach $ 15110 million by 2025, from $ 11450 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cancer Biomarkers business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Biomarkers market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Cancer Biomarkers, covering the supply chain analysis, impact assessment to the Cancer Biomarkers market size growth rate in several scenarios, and the measures to be undertaken by Cancer Biomarkers companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

• Protein Biomarkers
• Genetic Biomarkers
• Others

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

• Hospital
• Diagnostic Center
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Abbott Laboratories
• BioMerieux SA
• Thermo Fisher Scientific
• Illumina,Inc.
• Agilent Technologies
• F. Hoffmann-La Roche Ltd
• Hologic,Inc.
• Qiagen NV
• Novartis AG
• Merck & Co.
• Genomic Health
• Roche Diagnostics Ltd.
• Affymetrix

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Cancer Biomarkers consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Cancer Biomarkers market by identifying its various subsegments.
• Focuses on the key global Cancer Biomarkers manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Cancer Biomarkers with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Cancer Biomarkers submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cancer Biomarkers Consumption 2015-2025
  2.1.2 Cancer Biomarkers Consumption CAGR by Region
2.2 Cancer Biomarkers Segment by Type
  2.2.1 Protein Biomarkers
  2.2.2 Genetic Biomarkers
  2.2.3 Others
2.3 Cancer Biomarkers Consumption by Type
  2.3.1 Global Cancer Biomarkers Consumption Market Share by Type (2015-2020)
  2.3.2 Global Cancer Biomarkers Revenue and Market Share by Type (2015-2020)
  2.3.3 Global Cancer Biomarkers Sale Price by Type (2015-2020)
2.4 Cancer Biomarkers Segment by Application
  2.4.1 Hospital
  2.4.2 Diagnostic Center
  2.4.3 Others
2.5 Cancer Biomarkers Consumption by Application
  2.5.1 Global Cancer Biomarkers Consumption Market Share by Type (2015-2020)
  2.5.2 Global Cancer Biomarkers Value and Market Share by Type (2015-2020)
  2.5.3 Global Cancer Biomarkers Sale Price by Type (2015-2020)

3 GLOBAL CANCER BIOMARKERS BY COMPANY

3.1 Global Cancer Biomarkers Sales Market Share by Company
  3.1.1 Global Cancer Biomarkers Sales by Company (2018-2020)
  3.1.2 Global Cancer Biomarkers Sales Market Share by Company (2018-2020)
3.2 Global Cancer Biomarkers Revenue Market Share by Company
  3.2.1 Global Cancer Biomarkers Revenue by Company (2018-2020)
  3.2.2 Global Cancer Biomarkers Revenue Market Share by Company (2018-2020)
3.3 Global Cancer Biomarkers Sale Price by Company
3.4 Global Cancer Biomarkers Manufacturing Base Distribution, Sales Area, Type by Company
  3.4.1 Global Cancer Biomarkers Manufacturing Base Distribution and Sales Area by Company
  3.4.2 Players Cancer Biomarkers Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 CANCER BIOMARKERS BY REGIONS

4.1 Cancer Biomarkers by Regions
4.2 Americas Cancer Biomarkers Consumption Growth
4.3 APAC Cancer Biomarkers Consumption Growth
4.4 Europe Cancer Biomarkers Consumption Growth
4.5 Middle East & Africa Cancer Biomarkers Consumption Growth

5 AMERICAS

5.1 Americas Cancer Biomarkers Consumption by Countries
  5.1.1 Americas Cancer Biomarkers Consumption by Countries (2015-2020)
  5.1.2 Americas Cancer Biomarkers Value by Countries (2015-2020)
5.2 Americas Cancer Biomarkers Consumption by Type
5.3 Americas Cancer Biomarkers Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Cancer Biomarkers Consumption by Regions
  6.1.1 APAC Cancer Biomarkers Consumption by Regions (2015-2020)
  6.1.2 APAC Cancer Biomarkers Value by Regions (2015-2020)
6.2 APAC Cancer Biomarkers Consumption by Type
6.3 APAC Cancer Biomarkers Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 EUROPE

7.1 Europe Cancer Biomarkers by Countries
  7.1.1 Europe Cancer Biomarkers Consumption by Countries (2015-2020)
  7.1.2 Europe Cancer Biomarkers Value by Countries (2015-2020)
7.2 Europe Cancer Biomarkers Consumption by Type
7.3 Europe Cancer Biomarkers Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cancer Biomarkers by Countries
  8.1.1 Middle East & Africa Cancer Biomarkers Consumption by Countries (2015-2020)
  8.1.2 Middle East & Africa Cancer Biomarkers Value by Countries (2015-2020)
8.2 Middle East & Africa Cancer Biomarkers Consumption by Type
8.3 Middle East & Africa Cancer Biomarkers Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Channels
  10.1.2 Indirect Channels
10.2 Cancer Biomarkers Distributors
10.3 Cancer Biomarkers Customer

11 GLOBAL CANCER BIOMARKERS MARKET FORECAST

11.1 Global Cancer Biomarkers Consumption Forecast (2021-2025)
11.2 Global Cancer Biomarkers Forecast by Regions
  11.2.1 Global Cancer Biomarkers Forecast by Regions (2021-2025)
  11.2.2 Global Cancer Biomarkers Value Forecast by Regions (2021-2025)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Cancer Biomarkers Forecast by Type
11.8 Global Cancer Biomarkers Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Abbott Laboratories
  12.1.1 Company Information
  12.1.2 Cancer Biomarkers Product Offered
  12.1.3 Abbott Laboratories Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.1.4 Main Business Overview
  12.1.5 Abbott Laboratories Latest Developments
12.2 BioMerieux SA
  12.2.1 Company Information
  12.2.2 Cancer Biomarkers Product Offered
  12.2.3 BioMerieux SA Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.2.4 Main Business Overview
  12.2.5 BioMerieux SA Latest Developments
12.3 Thermo Fisher Scientific
  12.3.1 Company Information
  12.3.2 Cancer Biomarkers Product Offered
  12.3.3 Thermo Fisher Scientific Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.3.4 Main Business Overview
  12.3.5 Thermo Fisher Scientific Latest Developments
12.4 Illumina,Inc.
  12.4.1 Company Information
  12.4.2 Cancer Biomarkers Product Offered
  12.4.3 Illumina,Inc. Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.4.4 Main Business Overview
  12.4.5 Illumina,Inc. Latest Developments
12.5 Agilent Technologies
  12.5.1 Company Information
  12.5.2 Cancer Biomarkers Product Offered
  12.5.3 Agilent Technologies Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.5.4 Main Business Overview
  12.5.5 Agilent Technologies Latest Developments
12.6 F. Hoffmann-La Roche Ltd
  12.6.1 Company Information
  12.6.2 Cancer Biomarkers Product Offered
  12.6.3 F. Hoffmann-La Roche Ltd Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.6.4 Main Business Overview
  12.6.5 F. Hoffmann-La Roche Ltd Latest Developments
12.7 Hologic,Inc.
  12.7.1 Company Information
  12.7.2 Cancer Biomarkers Product Offered
  12.7.3 Hologic,Inc. Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.7.4 Main Business Overview
  12.7.5 Hologic,Inc. Latest Developments
12.8 Qiagen NV
  12.8.1 Company Information
  12.8.2 Cancer Biomarkers Product Offered
  12.8.3 Qiagen NV Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.8.4 Main Business Overview
  12.8.5 Qiagen NV Latest Developments
12.9 Novartis AG
  12.9.1 Company Information
  12.9.2 Cancer Biomarkers Product Offered
  12.9.3 Novartis AG Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.9.4 Main Business Overview
  12.9.5 Novartis AG Latest Developments
12.10 Merck & Co.
  12.10.1 Company Information
  12.10.2 Cancer Biomarkers Product Offered
  12.10.3 Merck & Co. Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.10.4 Main Business Overview
  12.10.5 Merck & Co. Latest Developments
12.11 Genomic Health
  12.11.1 Company Information
  12.11.2 Cancer Biomarkers Product Offered
  12.11.3 Genomic Health Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.11.4 Main Business Overview
  12.11.5 Genomic Health Latest Developments
12.12 Roche Diagnostics Ltd.
  12.12.1 Company Information
  12.12.2 Cancer Biomarkers Product Offered
  12.12.3 Roche Diagnostics Ltd. Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.12.4 Main Business Overview
  12.12.5 Roche Diagnostics Ltd. Latest Developments
12.13 Affymetrix
  12.13.1 Company Information
  12.13.2 Cancer Biomarkers Product Offered
  12.13.3 Affymetrix Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2018-2020)
  12.13.4 Main Business Overview
  12.13.5 Affymetrix Latest Developments

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Research Methodology
Table 2. Data Source
Table 3. Cancer Biomarkers Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Protein Biomarkers
Table 5. Major Players of Genetic Biomarkers
Table 6. Major Players of Others
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Cancer Biomarkers Consumption Market Share by Type (2015-2020)
Table 9. Global Cancer Biomarkers Revenue by Type (2015-2020) ($ million)
Table 10. Global Cancer Biomarkers Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Cancer Biomarkers Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Cancer Biomarkers Consumption Market Share by Application (2015-2020)
Table 14. Global Cancer Biomarkers Value by Application (2015-2020)
Table 15. Global Cancer Biomarkers Value Market Share by Application (2015-2020)
Table 16. Global Cancer Biomarkers Sale Price by Application (2015-2020)
Table 17. Global Cancer Biomarkers Sales by Company (2017-2019) (K MT)
Table 18. Global Cancer Biomarkers Sales Market Share by Company (2017-2019)
Table 19. Global Cancer Biomarkers Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Cancer Biomarkers Revenue Market Share by Company (2017-2019)
Table 21. Global Cancer Biomarkers Sale Price by Company (2017-2019)
Table 22. Global Cancer Biomarkers Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Cancer Biomarkers Products Offered
Table 24. Cancer Biomarkers Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Cancer Biomarkers Consumption by Regions 2015-2020 (K MT)
Table 26. Global Cancer Biomarkers Consumption Market Share by Regions 2015-2020
Table 27. Global Cancer Biomarkers Value by Regions 2015-2020 ($ Millions)
Table 28. Global Cancer Biomarkers Value Market Share by Regions 2015-2020
Table 29. Americas Cancer Biomarkers Consumption by Countries (2015-2020) (K MT)
Table 30. Americas Cancer Biomarkers Consumption Market Share by Countries (2015-2020)
Table 31. Americas Cancer Biomarkers Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Cancer Biomarkers Value Market Share by Countries (2015-2020)
Table 33. Americas Cancer Biomarkers Consumption by Type (2015-2020) (K MT)
Table 34. Americas Cancer Biomarkers Consumption Market Share by Type (2015-2020)
Table 35. Americas Cancer Biomarkers Consumption by Application (2015-2020) (K MT)
Table 36. Americas Cancer Biomarkers Consumption Market Share by Application (2015-2020)
Table 37. APAC Cancer Biomarkers Consumption by Regions (2015-2020) (K MT)
Table 38. APAC Cancer Biomarkers Consumption Market Share by Regions (2015-2020)
Table 39. APAC Cancer Biomarkers Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Cancer Biomarkers Value Market Share by Regions (2015-2020)
Table 41. APAC Cancer Biomarkers Consumption by Type (2015-2020) (K MT)
Table 42. APAC Cancer Biomarkers Consumption Market Share by Type (2015-2020)
Table 43. APAC Cancer Biomarkers Consumption by Application (2015-2020) (K MT)
Table 44. APAC Cancer Biomarkers Consumption Market Share by Application (2015-2020)
Table 45. Europe Cancer Biomarkers Consumption by Countries (2015-2020) (K MT)
Table 46. Europe Cancer Biomarkers Consumption Market Share by Countries (2015-2020)
Table 47. Europe Cancer Biomarkers Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Cancer Biomarkers Value Market Share by Countries (2015-2020)
Table 49. Europe Cancer Biomarkers Consumption by Type (2015-2020) (K MT)
Table 50. Europe Cancer Biomarkers Consumption Market Share by Type (2015-2020)
Table 51. Europe Cancer Biomarkers Consumption by Application (2015-2020) (K MT)
Table 52. Europe Cancer Biomarkers Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Cancer Biomarkers Consumption by Countries (2015-2020) (K MT)
Table 54. Middle East & Africa Cancer Biomarkers Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Cancer Biomarkers Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Cancer Biomarkers Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Cancer Biomarkers Consumption by Type (2015-2020) (K MT)
Table 58. Middle East & Africa Cancer Biomarkers Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Cancer Biomarkers Consumption by Application (2015-2020) (K MT)
Table 60. Middle East & Africa Cancer Biomarkers Consumption Market Share by Application (2015-2020)
Table 61. Cancer Biomarkers Distributors List
Table 62. Cancer Biomarkers Customer List
Table 63. Global Cancer Biomarkers Consumption Forecast by Countries (2021-2025) (K MT)
Table 64. Global Cancer Biomarkers Consumption Market Forecast by Regions
Table 65. Global Cancer Biomarkers Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Cancer Biomarkers Value Market Share Forecast by Regions
Table 67. Global Cancer Biomarkers Consumption Forecast by Type (2021-2025) (K MT)
Table 68. Global Cancer Biomarkers Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Cancer Biomarkers Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Cancer Biomarkers Value Market Share Forecast by Type (2021-2025)
Table 71. Global Cancer Biomarkers Consumption Forecast by Application (2021-2025) (K MT)
Table 72. Global Cancer Biomarkers Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Cancer Biomarkers Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Cancer Biomarkers Value Market Share Forecast by Application (2021-2025)
Table 75. Abbott Laboratories Product Offered
Table 76. Abbott Laboratories Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 77. Abbott Laboratories Main Business
Table 78. Abbott Laboratories Latest Developments
Table 79. Abbott Laboratories Basic Information, Company Total Revenue (in $ million), Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 80. BioMerieux SA Product Offered
Table 81. BioMerieux SA Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 82. BioMerieux SA Main Business
Table 83. BioMerieux SA Latest Developments
Table 84. BioMerieux SA Basic Information, Company Total Revenue (in $ million), Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 85. Thermo Fisher Scientific Product Offered
Table 86. Thermo Fisher Scientific Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 87. Thermo Fisher Scientific Main Business
Table 88. Thermo Fisher Scientific Latest Developments
Table 89. Thermo Fisher Scientific Basic Information, Company Total Revenue (in $ million), Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 90. Illumina,Inc. Product Offered
Table 91. Illumina,Inc. Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 92. Illumina,Inc. Main Business
Table 93. Illumina,Inc. Latest Developments
Table 94. Illumina,Inc. Basic Information, Company Total Revenue (in $ million), Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 95. Agilent Technologies Product Offered
Table 96. Agilent Technologies Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 97. Agilent Technologies Main Business
Table 98. Agilent Technologies Latest Developments
Table 99. Agilent Technologies Basic Information, Company Total Revenue (in $ million), Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 100. F. Hoffmann-La Roche Ltd Product Offered
Table 101. F. Hoffmann-La Roche Ltd Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 102. F. Hoffmann-La Roche Ltd Main Business
Table 103. F. Hoffmann-La Roche Ltd Latest Developments
Table 104. F. Hoffmann-La Roche Ltd Basic Information, Company Total Revenue (in $ million), Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 105. Hologic,Inc. Product Offered
Table 106. Hologic,Inc. Basic Information, Company Total Revenue (in $ million), Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 107. Hologic,Inc. Main Business
Table 108. Hologic,Inc. Latest Developments
Table 109. Hologic,Inc. Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 110. Qiagen NV Product Offered
Table 111. Qiagen NV Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 112. Qiagen NV Main Business
Table 113. Qiagen NV Latest Developments
Table 114. Qiagen NV Basic Information, Company Total Revenue (in $ million), Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 115. Novartis AG Product Offered
Table 116. Novartis AG Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 117. Novartis AG Main Business
Table 118. Novartis AG Latest Developments
Table 119. Novartis AG Basic Information, Company Total Revenue (in $ million), Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 120. Merck & Co. Product Offered
Table 121. Merck & Co. Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 122. Merck & Co. Main Business
Table 123. Merck & Co. Latest Developments
Table 124. Merck & Co. Basic Information, Company Total Revenue (in $ million), Cancer Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 125. Genomic Health Product Offered
Table 126. Genomic Health Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 127. Genomic Health Main Business
Table 128. Genomic Health Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Genomic Health Latest Developments
Table 130. Roche Diagnostics Ltd. Product Offered
Table 131. Roche Diagnostics Ltd. Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 132. Roche Diagnostics Ltd. Main Business
Table 133. Roche Diagnostics Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Roche Diagnostics Ltd. Latest Developments
Table 135. Affymetrix Product Offered
Table 136. Affymetrix Cancer Biomarkers Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)
Table 137. Affymetrix Main Business
Table 138. Affymetrix Latest Developments
Table 139. Affymetrix Basic Information, Manufacturing Base, Sales Area and Its Competitors

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Cancer Biomarkers
Figure 2. Cancer Biomarkers Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Cancer Biomarkers Consumption Growth Rate 2015-2025 (K MT)
Figure 5. Global Cancer Biomarkers Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Protein Biomarkers
Figure 7. Product Picture of Genetic Biomarkers
Figure 8. Product Picture of Others
Figure 9. Global Cancer Biomarkers Consumption Market Share by Type (2015-2020)
Figure 10. Global Cancer Biomarkers Value Market Share by Type (2015-2020)
Figure 11. Cancer Biomarkers Consumed in Hospital
Figure 12. Global Cancer Biomarkers Market: Hospital (2015-2020) (K MT)
Figure 13. Global Cancer Biomarkers Market: Hospital (2015-2020) ($ Millions)
Figure 14. Cancer Biomarkers Consumed in Diagnostic Center
Figure 15. Global Cancer Biomarkers Market: Diagnostic Center (2015-2020) (K MT)
Figure 16. Global Cancer Biomarkers Market: Diagnostic Center (2015-2020) ($ Millions)
Figure 17. Cancer Biomarkers Consumed in Others
Figure 18. Global Cancer Biomarkers Market: Others (2015-2020) (K MT)
Figure 19. Global Cancer Biomarkers Market: Others (2015-2020) ($ Millions)
Figure 20. Global Cancer Biomarkers Consumption Market Share by Application (2015-2020)
Figure 21. Global Cancer Biomarkers Value Market Share by Application (2015-2020)
Figure 22. Global Cancer Biomarkers Sales Market Share by Company in 2017
Figure 23. Global Cancer Biomarkers Sales Market Share by Company in 2019
Figure 24. Global Cancer Biomarkers Revenue Market Share by Company in 2017
Figure 25. Global Cancer Biomarkers Revenue Market Share by Company in 2019
Figure 26. Global Cancer Biomarkers Sale Price by Company in 2019
Figure 27. Global Cancer Biomarkers Consumption Market Share by Regions 2015-2020
Figure 28. Global Cancer Biomarkers Value Market Share by Regions 2015-2020
Figure 29. Americas Cancer Biomarkers Consumption 2015-2020 (K MT)
Figure 30. Americas Cancer Biomarkers Value 2015-2020 ($ Millions)
Figure 31. APAC Cancer Biomarkers Consumption 2015-2020 (K MT)
Figure 32. APAC Cancer Biomarkers Value 2015-2020 ($ Millions)
Figure 33. Europe Cancer Biomarkers Consumption 2015-2020 (K MT)
Figure 34. Europe Cancer Biomarkers Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Cancer Biomarkers Consumption 2015-2020 (K MT)
Figure 36. Middle East & Africa Cancer Biomarkers Value 2015-2020 ($ Millions)
Figure 37. Americas Cancer Biomarkers Consumption Market Share by Countries in 2019
Figure 38. Americas Cancer Biomarkers Value Market Share by Countries in 2019
Figure 39. Americas Cancer Biomarkers Consumption Market Share by Type in 2019
Figure 40. Americas Cancer Biomarkers Consumption Market Share by Application in 2019
Figure 41. United States Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 42. United States Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 44. Canada Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 46. Mexico Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Cancer Biomarkers Consumption Market Share by Countries in 2019
Figure 48. APAC Cancer Biomarkers Value Market Share by Regions in 2019
Figure 49. APAC Cancer Biomarkers Consumption Market Share by Type in 2019
Figure 50. APAC Cancer Biomarkers Consumption Market Share by Application in 2019
Figure 51. China Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 52. China Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 54. Japan Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 56. Korea Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 58. Southeast Asia Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 59. India Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 60. India Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 62. Australia Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Cancer Biomarkers Consumption Market Share by Countries in 2019
Figure 64. Europe Cancer Biomarkers Value Market Share by Countries in 2019
Figure 65. Europe Cancer Biomarkers Consumption Market Share by Type in 2019
Figure 66. Europe Cancer Biomarkers Consumption Market Share by Application in 2019
Figure 67. Germany Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 68. Germany Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 69. France Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 70. France Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 71. UK Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 72. UK Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 74. Italy Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 76. Russia Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Cancer Biomarkers Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Cancer Biomarkers Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Cancer Biomarkers Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Cancer Biomarkers Consumption Market Share by Application in 2019
Figure 81. Egypt Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 82. Egypt Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 84. South Africa Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 86. Israel Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 88. Turkey Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Cancer Biomarkers Consumption Growth 2015-2020 (K MT)
Figure 90. GCC Countries Cancer Biomarkers Value Growth 2015-2020 ($ Millions)
Figure 91. Global Cancer Biomarkers Consumption Growth Rate Forecast (2021-2025) (K MT)
Figure 92. Global Cancer Biomarkers Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 94. Americas Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 95. APAC Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 96. APAC Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 97. Europe Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 98. Europe Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 100. Middle East & Africa Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 101. United States Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 102. United States Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 103. Canada Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 104. Canada Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 105. Mexico Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 106. Mexico Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 107. Brazil Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 108. Brazil Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 109. China Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 110. China Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 111. Japan Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 112. Japan Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 113. Korea Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 114. Korea Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 116. Southeast Asia Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 117. India Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 118. India Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 119. Australia Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 120. Australia Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 121. Germany Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 122. Germany Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 123. France Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 124. France Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 125. UK Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 126. UK Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 127. Italy Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 128. Italy Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 129. Russia Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 130. Russia Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 131. Spain Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 132. Spain Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 133. Egypt Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 134. Egypt Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 135. South Africa Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 136. South Africa Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 137. Israel Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 138. Israel Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 139. Turkey Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 140. Turkey Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Cancer Biomarkers Consumption 2021-2025 (K MT)
Figure 142. GCC Countries Cancer Biomarkers Value 2021-2025 ($ Millions)
Figure 143. Abbott Laboratories Cancer Biomarkers Market Share (2018-2020)
Figure 144. BioMerieux SA Cancer Biomarkers Market Share (2018-2020)
Figure 145. Thermo Fisher Scientific Cancer Biomarkers Market Share (2018-2020)
Figure 146. Illumina,Inc. Cancer Biomarkers Market Share (2018-2020)
Figure 147. Agilent Technologies Cancer Biomarkers Market Share (2018-2020)
Figure 148. F. Hoffmann-La Roche Ltd Cancer Biomarkers Market Share (2018-2020)
Figure 149. Hologic,Inc. Cancer Biomarkers Market Share (2018-2020)
Figure 150. Qiagen NV Cancer Biomarkers Market Share (2018-2020)
Figure 151. Novartis AG Cancer Biomarkers Market Share (2018-2020)
Figure 152. Merck & Co. Cancer Biomarkers Market Share (2018-2020)
Figure 153. Genomic Health Cancer Biomarkers Market Share (2018-2020)
Figure 154. Roche Diagnostics Ltd. Cancer Biomarkers Market Share (2018-2020)
Figure 155. Affymetrix Cancer Biomarkers Market Share (2018-2020)